根据Nasdaq规则,生物技术公司未经股东批准向新雇员发放了股票。 Biotech firms granted stock to new hires without shareholder approval, per Nasdaq rules.

若干生物技术公司,包括PTC治疗公司、Abeona治疗公司、Abeona治疗公司、固体生物科学公司、Akebia治疗公司和Biomea Fusion公司,已宣布根据Nasdaq Listing规则第5635(c)(4)条向雇员提供奖励性股票补贴。 Several biotechnology companies, including PTC Therapeutics, Abeona Therapeutics, Solid Biosciences, Akebia Therapeutics, and Biomea Fusion, have announced employee inducement stock grants under Nasdaq Listing Rule 5635(c)(4). 这些赠款通常是为吸引新雇员而提供的,不受股东的许可。 These grants are typically made to attract new hires and are exempt from shareholder approval. 补助金的细节,如股份或价值的数目,没有列入公告中。 The details of the grants, such as the number of shares or value, were not included in the announcements.